New Molecule-Targeting Therapy with Herceptin (Trastuzumab), An anti-HER2 (c-erB-2) Monoclonal Antibody
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-10-01
著者
-
Sakamoto Goi
Department of Surgery and Pathology, Cancer Institute Hospital
-
Sakamoto Goi
Department Of Breast Pathology Cancer Institute
-
MITSUYAMA Shoshu
Deputy President of the Kitakyushu Municipal Medical Center
関連論文
- Overrepresentation of the EBAG9 Gene at 8q23 Associated with Early-Stage Breast Cancers
- Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
- Detailed Deletion Mapping of Chromosome Arm 3p in Breast Cancers : A 2-cM Region on 3p 14.3-21.1 and a 5-cM Region on 3p 24.3-25.1 Commonly Deleted in Tumors
- Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
- Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Adenoid cystic carcinoma with collagenous spherulosis-like structures in the breast : Report of a case
- Identification of Rad51 alteration in patients with bilateral breast cancer
- Muco-epidermoid carcinoma of the breast
- Correlation of Allelic Losses and Clinicopathological Factors in 504 Primary Breast Cancers
- Allelic Loss at 1p34-36 Predicts Poor Prognosis in Node-negative Breast Cancer
- Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma
- Evaluation of HER2 Status: For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab) (Pathological Committee for Optimal Use of Trastuzumab)
- Surgery for Ductal Carcinoma in situ
- Mapping of a New Target Region of Allelic Loss to a 6-cM Interval at 21q21 in Primary Breast Cancers
- Diagnostic Mammography and Ultrasonography for Palpable and Nonpalpable Breast Cancer in Women Aged 30 to 39 Years
- Diagnostic Ultrasonography and Mammography for Invasive and Noninvasive Breast Cancer in Women Aged 30 to 39 Years
- What is the Predictor for Invasion in Non-palpable Breast Cancer with Microcalcifications?
- Mammographic and Clinicopathological Features of Mucinous Carcinoma of the Breast
- Clinical and Pathologic Features of Fibroadenoma of the Mastopathic Type
- Clinical and Pathologic Features of Invasive Micropapillary Carcinoma
- Frequent Allelic Loss at 7p14-15 Associated with Aggressive Histologic Types of Breast Cancer
- Mapping of a New Target Region of Allelic Loss to a 2-cM Interval at 22q 13.1 in Primary Breast Cancer
- A Clinicopathologic Study of Breast Cancer Patients during Pregnancy
- Endoscopic Classification of Intraductal Lesions and Histological Diagnosis
- Mutation Analysis of the mel-18 Gene that Shows Decreased Expression in Human Breast Cancer Cell Lines
- Overexpression of Her2/neu, Estrogen and Progesterone Receptors in Invasive Micropapillary Carcinoma of the Breast
- Evaluation of HER-2 Status in Breast Carcinoma by Fluorescence in situ Hybridization and Immunohistochemistry
- Allelic Loss on Chromosome 1p Is Associated with Progression and Lymph Node Metastasis of Primary Breast Carcinoma
- A Case of Leiomyoma of the Breast
- Evaluation of the Interobserver Agreement in the Number of Mitotic Figures of Breast Carcinoma as Simulation of Quality Monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Protocol
- Allelic losses as prognostic markers for breast cancers
- Mapping of Target Regions of Allelic Loss in Primary Breast Cancers to 1-cM Intervals on Genomic Contigs at 6q21 and 6q25.3
- A Comparison of MR Imaging, Galactography and Ultrasonography in Patients with Nipple Discharge
- Malignant Melanoma Originating on the Female Nipple : A Case Report
- A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study
- New Molecule-Targeting Therapy with Herceptin (Trastuzumab), An anti-HER2 (c-erB-2) Monoclonal Antibody
- Synchronous Bilateral Noninvasive Ductal Carcinoma of the Male Breast: A Case Report
- Risk Factors for Breast Cancer among Japanese Women in Tokyo : A Case-Control Study